罗氏口服SERD药物二期临床试验再传捷报，三期辅助乳腺癌试验达标——Fierce Biotech报道

Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial  Fierce Biotech